The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication.
about
The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells.In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation.What can we do to reduce the viral reservoir in HIV-1-infected individuals?Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral TherapyThalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?Effects of exosome on the activation of CD4+ T cells in rhesus macaques: a potential application for HIV latency reactivation.Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation.Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.Elimination of HIV-1 Latently Infected Cells by Gnidimacrin and a Selective HDAC Inhibitor.Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths.Novel Latency Reversal Agents for HIV-1 Cure.Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4 T Cells Harboring Reactivated Human Immunodeficiency Virus
P2860
Q36361960-2C83131E-E5BE-4340-8957-3518512B13EEQ37493633-C74C3A22-D5F0-4E2C-84D9-314F810B061EQ38841879-F33BCBD1-4B3A-4495-8ABE-F0E5B60680DCQ38971085-B5CD56EA-E54A-4D7D-A992-6FD90F92543BQ40069617-00670F6A-EACA-48DF-8EE7-A7C4F64C80D3Q45908717-94AA7A91-B6BE-4F34-ADAF-A8B91C1795B4Q47201695-3102C4A0-2FE8-4337-85B5-51DED8AF6C3AQ47550536-B49EFE58-67C1-495A-B778-43B085BC739DQ47600020-241FA29E-A29E-49FC-B70F-0D7CA198A29BQ51740044-C83C55D0-AE6B-4282-8D7A-D4F8587A6F97Q52431127-5376EF71-882F-4790-A867-3963D4452532Q52803378-4EB5C365-DE47-4893-A6D1-CCBD239C3020Q52816327-ADB729B7-7602-4613-8187-73B175EF8E6DQ55455666-B13DC102-D123-4A49-8164-84A631189B8AQ57565007-D62C5F61-11B8-4ECE-ACBB-0E36209E27D5
P2860
The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@en
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@nl
type
label
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@en
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@nl
prefLabel
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@en
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@nl
P2093
P2860
P1433
P1476
The Effect of Latency Reversal ...... odeficiency Virus Eradication.
@en
P2093
Christopher W Pohlmeyer
Joel N Blankson
Patrick M Tarwater
Victoria E Walker-Sperling
P2860
P304
P356
10.1016/J.EBIOM.2016.04.019
P577
2016-04-18T00:00:00Z